The Prognostic Value Of Serum Albumin In Acute Ischemic Stroke Patients

Authors

  • Ahmad Alrjjo Tishreen University
  • Hala Saied Tishreen University
  • Youssef Zreik Tishreen University

Abstract

Background: Stroke is one of the most common causes of death and disability in the world. Determining mortality indicators is vital so that immediate remedial measures can be taken to improve outcome. Previous studies have identified factors such as stroke severity, stroke type, aging, impaired consciousness and hyperglycemia as indicators of mortality for acute stroke, but mortality remains high among patients hospitalized with acute stroke.

 

Objectives: study of the relationship between low serum albumin during the first week of acute   ischemic stroke and residual rate and degree of functional disability according to (mRS) after 30 days.

 

Methods and patients: Our study included 135 acute ischemic stroke patients and followed up for one month in terms of mortality and functional outcome. Albumin levels were determined in the first week of admission. We also performed a comprehensive neurological examination and determined the severity of stroke according to NIHSS. Brain CT scan was also performed.

 

Results Patients with poor prognosis (mRS≥4) had significantly low albumin levels ​​than patients with good prognosis (mRS≤3)

(p-value<0.001).

Conclusions: Lower serum albumin level is a strong and an independent predictor for one month unfavorable outcomes in patients with first-ever acute ischemic stroke.

Downloads

Published

2022-09-08

How to Cite

1.
الرجو أ, هالة سعيد, يوسف زريق. The Prognostic Value Of Serum Albumin In Acute Ischemic Stroke Patients. Tuj-hlth [Internet]. 2022Sep.8 [cited 2024Nov.24];44(4):411-29. Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/13317

Issue

Vol. 44 No. 4 (2022): Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

Section

Master student researches

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.